Clinical Trial Update: A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. [Phase 3]

View source ↗

Summary

Clinical trial update announcing a Phase 3 long-term study of ritlecitinib in children with severe alopecia areata; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Severe Alopecia Areata | Phase 3 | Status: RECRUITING